Skip to main content
REQUEST AN INVITE FOR 2026
Agenda
Faculty
Sponsorship
Accommodations
Policies
FAQs
Registration
DCLF 2025 Event Video
connect with us
2026 Agenda
2026 Agenda
2026 Agenda
Monday, March 16, 2026
5:00 PM - 6:30 PM
Welcome Cocktail Reception
Tuesday, March 17, 2026
7:30 AM - 8:30 AM
Breakfast
8:30 AM - 8:45 AM
Conference Welcome Remarks
Paula B. Fein, MSEd
Vice President | Drug Channels Institute
8:45 AM - 9:15 AM
Keynote
Adam J. Fein, PhD
President | Drug Channels Institute
9:15 AM - 10:00 AM
Fireside Chat with Debbie Weitzman
Panelist
Debbie Weitzman
CEO, Pharmaceutical & Specialty Solutions | Cardinal Health
Moderator
Adam J. Fein, PhD
President | Drug Channels Institute
10:00 AM - 10:15 AM
Coffee Break
10:15 AM - 11:00 AM
Wall Street Controversies on Drug Channel Companies
Panelist
Elizabeth Anderson, MBA
Senior Managing Director | Evercore ISI
Panelist
Michael Cherny
Senior Managing Director | Leerink Partners
Panelist
George Hill
Managing Director & Lead Analyst, Healthcare Technology & Service | Deutsche Bank Securities Inc.
Moderator
Brian Reid, MS
Principal | Reid Strategic
11:00 AM - 11:45 AM
What's Next for Provider-Administered Drugs and Buy-and-Bill
Panelist
Saira A. Jan, MS, PharmD
Vice President & Chief Pharmacy Officer | Horizon Blue Cross Blue Shield of New Jersey
Panelist
Debra Patt, MD, PhD, MBA
Executive Vice President, Policy and Strategy | Texas Oncology
Panelist
Lisa Thompson Smith, RPh
SVP & President, Specialty Distribution and Solutions | Cencora
Moderator
Milena Sullivan
Senior Vice President and Head of Policy Advisory Practice | Avalere Health
11:45 AM - 1:00 PM
Lunch
1:00 PM - 2:00 PM
Keynote + Fireside Chat with Eric Percher
Keynote Speakear
Eric Percher
Co-Founder, Lead Analyst Pharma Supply Chain & Digital Health | Nephron Research
Moderator
Adam J. Fein, PhD
President | Drug Channels Institute
2:00 PM - 2:45 PM
Fireside Chat with Mostafa Kamal
Panelist
Mostafa Kamal
President and Chief Executive Officer | Prime Therapeutics
Moderator
Adam J. Fein, PhD
President | Drug Channels Institute
2:45 PM - 3:00 PM
Coffee Break
3:00 PM - 3:30 PM
Roundtable Discussion Exercise
Adam J. Fein, PhD
President | Drug Channels Institute
3:30 PM - 4:15 PM
Crossfire: The 340B Drug Pricing Program
Panelist
John M. O'Brien, PharmD, MPH
President and Chief Executive Officer | National Pharmaceutical Council
Panelist
Maureen Testoni, JD
President and Chief Executive Officer | 340B Health
Moderator
Luke Greenwalt, MBA
VP and Lead, IQVIA Market Access Center of Excellence | IQVIA
4:15 PM - 5:00 PM
Fireside Chat with Kevin Host
Panelist
Kevin Host, PharmD
Senior Vice President, Pharmacy | Walmart
Moderator
Adam J. Fein, PhD
President | Drug Channels Institute
5:00 PM - 5:15 PM
Day 1 Closing Remarks
Adam J. Fein, PhD
President | Drug Channels Institute
6:00 PM - 8:00 PM
Outdoor Dinner Reception
Wednesday, March 18, 2026
7:30 AM - 8:30 AM
Breakfast
8:30 AM - 9:30 AM
Keynote + Fireside Chat with Antonio Ciaccia
Keynote Speaker
Antonio Ciaccia
President | 3 Axis Advisors , Chief Executive Officer | 46brooklyn Research
Moderator
Adam J. Fein, PhD
President | Drug Channels Institute
9:30 AM - 10:15 AM
The View from the Payer
Panelist
Shawn Gremminger
President and CEO | The National Alliance of Healthcare Purchaser Coalitions
Panelist
Mike Jansen
Senior Director, Benefits & Wellbeing | Walmart Stores, Inc.
Panelist
Rosa Novo
Administrative Benefits Director | Miami-Dade County Public Schools
Moderator
Bryce Platt, PharmD, RPh
Pharmacy Management Consultant | Milliman
10:15 AM - 10:30 AM
Coffee Break
10:30 AM - 11:15 AM
How Patient-Paid Prescriptions are Changing the Drug Channel
Panelist
Wendy Barnes
President and CEO | GoodRx
Panelist
John Love
Vice President | Amazon Pharmacy
Panelist
Jennifer Mazur, MBA
General Manager, US LillyDirect; Senior Vice President, Lilly USA Consumer Hub | Eli Lilly and Company
Moderator
Jailendra Singh, MBA
Managing Director | Truist Securities
11:15 AM - 12:00 PM
Fireside Chat with Jeff Davis, Christine Marsh, and Jennifer Norton
Panelist
Jeff Davis
Executive Director, National Channel | AstraZeneca
Panelist
Christine G. Marsh, MBA
Senior Vice President, Value & Access | Boehringer Ingelheim
Panelist
Jennifer Norton
Senior Vice President, Patient and Market Access | Takeda Pharmaceuticals
Moderator
Adam J. Fein, PhD
President | Drug Channels Institute
12:00 PM - 12:05 PM
Conference Closing Remarks
Adam J. Fein, PhD
President | Drug Channels Institute
Back to top